1. Chromosomes and Gene Expression
  2. Genetics and Genomics
Download icon

Translational control of one-carbon metabolism underpins ribosomal protein phenotypes in cell division and longevity

  1. Nairita Maitra
  2. Chong He
  3. Heidi M Blank
  4. Mitsuhiro Tsuchiya
  5. Birgit Schilling
  6. Matt Kaeberlein
  7. Rodolfo Aramayo
  8. Brian K Kennedy  Is a corresponding author
  9. Michael Polymenis  Is a corresponding author
  1. Texas A&M University, United States
  2. Buck Institute for Research on Aging, United States
  3. University of Washington, United States
  4. Buck Institute For Research On Aging, United States
  5. National University of Singapore, Singapore
Research Article
  • Cited 4
  • Views 2,586
  • Annotations
Cite this article as: eLife 2020;9:e53127 doi: 10.7554/eLife.53127

Abstract

A long-standing problem is how cells that lack one of the highly similar ribosomal proteins (RPs) often display distinct phenotypes. Yeast and other organisms live longer when they lack specific ribosomal proteins, especially of the large 60S subunit of the ribosome. However, longevity is neither associated with the generation time of RP deletion mutants nor with bulk inhibition of protein synthesis. Here, we queried actively dividing RP mutants through the cell cycle. Our data link transcriptional, translational, and metabolic changes to phenotypes associated with the loss of paralogous RPs. We uncovered translational control of transcripts encoding enzymes of methionine and serine metabolism, which are part of one-carbon (1C) pathways. Cells lacking Rpl22Ap, which are long-lived, have lower levels of metabolites associated with 1C metabolism. Loss of 1C enzymes increased the longevity of wild type cells. 1C pathways exist in all organisms and targeting the relevant enzymes could represent longevity interventions.

Data availability

Sequencing data have been deposited in GEO under accession code GSE135336. All data generated or analysed during this study are included in the manuscript and supporting files.

The following data sets were generated

Article and author information

Author details

  1. Nairita Maitra

    Biochemistry and Biophysics, Texas A&M University, College Station, United States
    Competing interests
    No competing interests declared.
  2. Chong He

    Buck Institute for Research on Aging, Novato, United States
    Competing interests
    No competing interests declared.
  3. Heidi M Blank

    Biochemistry and Biophysics, Texas A&M University, College Station, United States
    Competing interests
    No competing interests declared.
  4. Mitsuhiro Tsuchiya

    Pathology, University of Washington, Seattle, United States
    Competing interests
    No competing interests declared.
  5. Birgit Schilling

    Buck Institute For Research On Aging, Novato, United States
    Competing interests
    No competing interests declared.
  6. Matt Kaeberlein

    Department of Pathology, University of Washington, Seattle, United States
    Competing interests
    Matt Kaeberlein, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1311-3421
  7. Rodolfo Aramayo

    Biology, Texas A&M University, College Station, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9702-6204
  8. Brian K Kennedy

    National University of Singapore, Singapore, Singapore
    For correspondence
    bkennedy@nus.edu.sg
    Competing interests
    No competing interests declared.
  9. Michael Polymenis

    Biochemistry and Biophysics, Texas A&M University, College Station, United States
    For correspondence
    polymenis@tamu.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1507-0936

Funding

National Institutes of Health (GM123139)

  • Rodolfo Aramayo
  • Brian K Kennedy
  • Michael Polymenis

National Center for Research Resources (1S10 OD016281)

  • Birgit Schilling

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Jeff Smith, University of Virginia, United States

Publication history

  1. Received: October 29, 2019
  2. Accepted: May 20, 2020
  3. Accepted Manuscript published: May 20, 2020 (version 1)
  4. Version of Record published: June 1, 2020 (version 2)

Copyright

© 2020, Maitra et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,586
    Page views
  • 368
    Downloads
  • 4
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

Further reading

    1. Chromosomes and Gene Expression
    2. Genetics and Genomics
    David M Garcia et al.
    Research Article

    In fluctuating environments, switching between different growth strategies, such as those affecting cell size and proliferation, can be advantageous to an organism. Trade-offs arise, however. Mechanisms that aberrantly increase cell size or proliferation—such as mutations or chemicals that interfere with growth regulatory pathways—can also shorten lifespan. Here we report a natural example of how the interplay between growth and lifespan can be epigenetically controlled. We find that a highly conserved RNA-modifying enzyme, the pseudouridine synthase Pus4/TruB, can act as a prion, endowing yeast with greater proliferation rates at the cost of a shortened lifespan. Cells harboring the prion grow larger and exhibit altered protein synthesis. This epigenetic state, [BIG+] (better in growth), allows cells to heritably yet reversibly alter their translational program, leading to the differential synthesis of dozens of proteins, including many that regulate proliferation and aging. Our data reveal a new role for prion-based control of an RNA-modifying enzyme in driving heritable epigenetic states that transform cell growth and survival.

    1. Chromosomes and Gene Expression
    Alessandro Stirpe et al.
    Research Article

    The SUV39 class of methyltransferase enzymes deposits histone H3 lysine 9 di- and trimethylation (H3K9me2/3), the hallmark of constitutive heterochromatin. How these enzymes are regulated to mark specific genomic regions as heterochromatic is poorly understood. Clr4 is the sole H3K9me2/3 methyltransferase in the fission yeast Schizosaccharomyces pombe, and recent evidence suggests that ubiquitination of lysine 14 on histone H3 (H3K14ub) plays a key role in H3K9 methylation. However, the molecular mechanism of this regulation and its role in heterochromatin formation remain to be determined. Our structure-function approach shows that the H3K14ub substrate binds specifically and tightly to the catalytic domain of Clr4, and thereby stimulates the enzyme by over 250-fold. Mutations that disrupt this mechanism lead to a loss of H3K9me2/3 and abolish heterochromatin silencing similar to clr4 deletion. Comparison with mammalian SET domain proteins suggests that the Clr4 SET domain harbors a conserved sensor for H3K14ub, which mediates licensing of heterochromatin formation.